Ankylosing spondylitis: Recent developments and anaesthetic implications

Anaesthesia

Volumn 64, Issue 5, 2009, Pages 540-548

  Woodward, L J ^a   Kam, Peter C A ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; CERTOLIZUMAB PEGOL; CORTICOSTEROID; ETANERCEPT; HLA B27 ANTIGEN; HLA B60 ANTIGEN; INFLIXIMAB; LEFLUNOMIDE; LYMPHOTOXIN; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; SALAZOSULFAPYRIDINE; THALIDOMIDE; TUMOR NECROSIS FACTOR ALPHA;

AIRWAY; ANESTHESIA COMPLICATION; ANKYLOSING SPONDYLITIS; CLINICAL FEATURE; DRUG CONTRAINDICATION; DRUG HALF LIFE; ENDOTRACHEAL INTUBATION; GENERAL ANESTHESIA; HUMAN; IMMUNOPATHOGENESIS; KNEE SURGERY; LARYNGEAL MASK; LOCAL ANESTHESIA; OBSTETRIC ANESTHESIA; PREOPERATIVE CARE; REGIONAL ANESTHESIA; REVIEW; SPINE SURGERY;

ADULT; ANESTHESIA; ANTIRHEUMATIC AGENTS; FEMALE; HUMANS; INTUBATION, INTRATRACHEAL; MALE; SPONDYLITIS, ANKYLOSING; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 66049146089     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/j.1365-2044.2008.05794.x     Document Type: Review

References (64)

1. Lawrence RC, Helmick CG, Arnett FC, et al. Estimates of prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis 1998; 41: 778-799
2. Sieper J, Rudwleit M, Khan MA, Braun J. Concepts and epidemiology of spondyloarthritis. Best Practice and Research. Clinical Rheumatology 2006; 20: 401-417
3. Akkoc N, Khan MA. Epidemiology of ankylosing spondylitis and related spondyloarthopathies. In: Weisman MH, Reveille JD, van der Heijde D, eds. Ankylosing Spondylitis and the Spondyloarthropathies. London: Mosby, 2005: 117-131
4. Gran JT, Husby G, Hordvik M. Prevalence of ankylosing spondylitis in males and females in a young middle-aged population of Tromso, northern Norway. Annals of Rheumatic Diseases 1985; 44: 359-367 (Pubitemid 15053515)
5. Hoyle E, Laval SH, Calin A, Wordsworth BP, Brown MA. The X-chromosome and susceptibility to ankylosing spondylitis. Arthritis and Rheumatism 2000; 43: 1353-1355 (Pubitemid 30416321)
6. Mori K, Ushiyama T, Inoue K, Hukuda S. Polymorphic CAG repeats of the androgen receptor gene in Japanese male patients with ankylosing spondylitis. Rheumatology (Oxford) 2000; 39: 530-532 (Pubitemid 30352957)
7. Jimenez-Balderas FJ, Mintz G. Ankylosing spondylitis: clinical course in women and men. Journal of Rheumatology 1993; 20: 2069-2072 (Pubitemid 24043131)
8. Brophy S, Calin A. Ankylosing spondylitis: interaction between genes, joints, age at onset and disease expression. Journal of Rheumatology 2001; 28: 2283-2288 (Pubitemid 32947876)
9. Dakwar E, Reddy J, Vale F, Uribe J. A review of the pathogenesis of ankylosing spondylitis. Neurosurgical Focus 2008; 24: E2.
10. Burton PR et al. for the Wellcome Trust Case Control Consortium and the Australo-Anglo-American Spondylitis Consortium. Association scan of 14.500 nonosynonymous SNPs in four diseases identifies autoimmunity variants. Nature Genetics 2007; 39: 1329-1337
11. Feldtkeller E, Khan MA, van der Heijde D, van der Linden S, Braun J. Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis. Arthritis and Rheumatism 1977; 20: 909-912
12. Calin A. Ankylosing spondylitis. Medicine 2006; 34: 10.
13. Fiorillo MT, Ruckert C, Hulsmeyer M, et al. Alleedependent similarity between viral and self-peptide presentation by HLA-B27 subtypes. Journal of Biological Chemistry 2005; 280: 2962-2971
14. Gu J, Rihil M, Marker-Hermann E, et al. Clues to pathogenesis of spondyloarthropathy derived from synovial fluid mononuclear cell gene expression profiles. Journal of Rheumatology 2002; 29: 2159-2164
15. De Vos M, Cuvelier C, Mielants H, Veys E, Barbier F, Elewaut A. Ileocolonoscopy in seronegative spondyloarthropathy. Gastrenterology 1989; 96: 339-344
16. Braun J, Bollow M, Neure L, et al. Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis. Arthritis and Rheumatism 2006; 54: 499-505.
17. Shaikh S. Ankylosing spondylitis: recent breakthroughs in diagnosis and treatment. Journal of the Canadian Chiropractic Association 2007; 51: 249-260
18. Jacobs WB, Fehlings MG. Ankylosing spondylitis and spinal cord injury: origin, incidence, management and avoidance. Neurosurgical Focus 2008; 24: E12.
19. Tico N, Ramon S, Garcia-Ortun F, et al. Traumatic spinal cord injury, complicating ankylosing spondylitis. Spinal Cord 1998; 36: 349-352
20. Peters MJ, van der Horst-Bruinsma IE, Dijkmans BA, Nurmohamed MR. Cardiovascular risk profile of patients with spondyloarthropathies, particularly ankylosing spondylitis and psoriatic arthritis. Seminars in Arthritis and Rheumatism 2004; 34: 585-589
21. Brophy S, Pavy S, Lewis P, et al. Inflammatory eye, skin and bowel disease. Best Practice and Research. Clinical Rheumatology 2002; 16: 537-549
22. Braun J, Sieper J. Ankylosing spondylitis. Lancet 2007; 369: 1379-1390 (Pubitemid 46590387)
23. van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis and Rheumatism 1984; 27: 361-368
24. Feldtkeller E. Age of disease onset and delayed diagnosis of spondyloarthropathies. Journal of Rheumatology 1999; 58: 21-30. (Pubitemid 29128474)
25. Rudwaleit M, Metter A, Listing J, Sieper J, Braun J. Inflammatory back pain in ankylosing spondylitis: a reassessment of the clinical history for application as classification and diagnostic criteria. Arthritis and Rheumatism 2006; 54: 569-578 (Pubitemid 43228633)
26. Spoorenberg A, van der Heijde D, de Klerk E, et al. Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis. Journal of Rheumatology 1999; 26: 980-984 (Pubitemid 29195698)
27. Rudwaleit M, Khan MA. The challenge of diagnosis and classification in early ankylosing spondylitis: do we need a new criteria? Arthritis and Rheumatism 2005; 52: 1000-1008
28. Blum U, Buitrago-Tellez C, Mundinger A, et al. Magnetic resonance imaging (MRI) for detection of active sacroilitis - a prospective study comparing conventional radiography, scintography and contrast enhanced MRI. Journal of Rheumatology 1996; 23: 2107-2115 (Pubitemid 27006759)
29. van Tubergen A, Landewe R, van der Heijde D, et al. Combined spa exercise therapy is effective in patients with Ankylosing Spondylitis: a randomised controlled trial. Arthritis and Rheumatism 2001; 45: 430-438
30. Wanders A, Heijde D, Landewe R, et al. Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomised controlled trial. Arthritis and Rheumatism 2005; 52: 1756-1765
31. Maksmowych WP, Jhangri GS, Fitzgerald AA, et al. A six month randomised controlled, double blind, dose response comparison of intravenous pamidronate in the treatment of non steroidal anti-inflammatory drug refractory ankylosing spondylitis. Arthritis and Rheumatism 2002; 46: 766-773
32. Dougados M, Dijkmans B, Khan M, Maksymowych W, van der Linden SJ, Brandt J. Conventional treatments for ankylosing spondylitis. Annals of Rheumatic Disease 2002; 61: 40-50. (Pubitemid 35397344)
33. Palladino MA, Bahjat FR, Theodorakis EA, Moldawer LL. Anti-TNF-α therapies: the next generation. Nature Reviews Drug Discovery 2003; 2: 736-746
34. Braun J, Baraliakos X, Golder W, et al. Magnetic resonance imaging examination in patients with ankylosing spondylitis before and after successful therapy with infliximab: evaluation of a new scoring system. Arthritis and Rheumatism 2003; 48: 1126-1136
35. McLeod C, Bagust A, Boland A, et al. Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systemic review and economic evaluation. Health Technology Assessment 2007; 28: 1-158.
36. Furst DE, Breedveld FC, Kalden JR, et al. Updated consensus statement on biological agents for the treatment of rheumatic diseases. Annals of the Rheumatic Diseases 2007; 66 (Suppl. 3): 2-22.
37. Van der Heijde D, Dijkmans B, Geusens P, et al. Ankylosing spondylitis study for the evaluation of recombinant infliximab therapy study group. Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomised placebo-controlled trial. Arthritis and Rheumatism 2005; 52: 582-591
38. Davis JC, van der Heijde D, Braun J, et al. Recombinant human tissue necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomised controlled trial. Arthritis and Rheumatism 2003; 48: 3260-3266
39. Van der Heijde D, Kivitz A, Schiff M, et al. Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicentre randomised, double blind placebo controlled trial. Arthritis and Rheumatism 2006; 54: 2136-2146
40. Ramos-Casals M, Brito-Zeron P, Munoz S, et al. Autoimmune diseases induced by TNF targeted therapies: analysis of 233 cases. Medicine 2007; 86: 242-251
41. Stubgen JP. Tumour necrosis factor-a antagonists and neuropathy. Muscle and Nerve 2008; 37: 281-292
42. Desai SB, Furnst DE, Pearson CM. Problems encountered during anti-tumour necrosis factor therapy. Best Practice and Research. Clinical Rheumatology 2006; 20: 757-790
43. Askling J, Fored CM, Baecklund E, et al. Hematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists. Annals of Rheumatic Diseases 2005; 64: 1414-1420
44. Braun J, Davis J, Dougados M, Sieper J, van der Linden S, van der Heijde D. First update of the international ASAS consensus statement of the use of antiTNF agents in patients with ankylosing spondylitis. Annals of Rheumatic Diseases 2006; 65: 316-320 (Pubitemid 43268219)
45. Tan AL, Marzo-Ortego H, O'Connor P, Fraser A, Emery P, McGonagle D. Efficacy of anakira in active ankylosing spindylitis: a clinical and magnetic resonance imaging study. Annals of Rheumatic Diseases 2004; 63: 1158-1166 (Pubitemid 39120352)
46. Haibel H, Rudaleit M, Listing L, Sieper J. Open label trial of anakira in active ankylosing spondylitis over 24 weeks. Annals of Rheumatic Diseases 2005; 64: 296-298 (Pubitemid 40193630)
47. Hoh DJ, Khoueir P, Wang MY. Management of cervical deformity in ankylosing spondylitis. Neurosurgical Focus 2008; 24: E9.
48. Giles JT, Bartlett SJ, Gelber AC, et al. Tumour necrosis factor inhibitor therapy and risk of serious postoperative orthopaedic infection in rheumatoid arthritis. Arthritis and Rheumatism 2006; 55: 333-337
49. Chang J, Girgis L. Clinical use of anti-TNF-α biological agents. A guide for GPs. Australian Family Physician 2007; 36: 1035-1038
50. Nederlandse Vereniging voor Reumatologie. Medicijnen: Het toepassen van TNF blockade in de behandeling van reumatoide arteritis. Dutch Society for Rhematology 2003. http:// www.nvr.nl (accessed 11 July 2008).
51. den Broeder AA, Creemers MCW, Fransen J, et al. Risk factors for surgical site infections and other complications in elective surgery in patients with rheumatoid arthritis with special attention for anti-tumour necrosis factor: a large retrospective study. Journal of Rheumatology 2007; 34: 689-695 (Pubitemid 46641372)
52. Branten AJW. Risk of infectious complications during anti- TNFa therapy. Netherlands Journal of Medicine 2008; 66: 2.
53. Hill CM. Death following dental clearance in a patient suffering from ankylosing spondylitis. British Journal of Oral Surgery 1980; 18: 73-76
54. Lu PPL, Brimacombe J, Ho ACY, Shyr MH, Liu HP. The intubating laryngeal mask airway in severe ankylosing spondylitis. Canadian Journal of Anaesthesia 2001; 48: 1015-1019 (Pubitemid 34092923)
55. Asai T, Wagle AU, Stacey M. Placement of the intubating laryngeal mask is easier than the laryngeal mask during manual in-line neck immobilisation. British Journal of Anaesthesia 1999; 82: 712-714 (Pubitemid 29199744)
56. Lucas DN, Yentis SM. A comparison of the intubating laryngeal mask tracheal tube with a standard tracheal tube for fibre-optic intubation. Anaesthesia 2000; 55: 358-361 (Pubitemid 30209455)
57. Lai HY, Chen IH, Chen A, Hwang FY, Lee Y. The use of the Glidescope® for tracheal intubation in patients with Ankylosing Spondylitis. British Journal of Anaesthesia 2006; 97: 419-422 (Pubitemid 44295683)
58. Kumar CM, Mehta M. Ankylosing Spondylitis: lateral approach to spinal anaesthesia for lower limb surgery. Canadian Journal of Anaesthesia 1995; 42: 73-76
59. Wulf H. Epidural anaesthesia and spinal haematoma. Canadian Journal of Anaesthesia 1996; 43: 1260-1271 (Pubitemid 27086664)
60. Hyderally H. Epidural haematoma unrelated to combined spinal epidural anaesthesia in a patient with ankylosing spondylitis receiving aspirin after total hip replacement. Anesthesia and Analgesia 2005; 100: 882-883 (Pubitemid 40300092)
61. Batra YK, Sharma A, Rajeev S. Total spinal anaesthesia following epidural test dose in an ankylosing spondyltic patient with anticipated difficult airway undergoing total hip replacement. European Journal of Anaesthesiology 2006; 23:890-898 (Pubitemid 44464945)
62. Dougados M, Dijkmans B, Khan M, Maksymowych W, van der Linden SJ, Brandt J. Conventional treatments for ankylosing spondylitis. Annals of Rheumatic Diseases 2002; 61: 40-50. (Pubitemid 35397344)
63. Rodi Z, Straus I, Denic K, Deletis V, Vodusek D. Transient paraplegia revealed by intraoperative neurophysiological monitoring: was it caused by the epidural anaesthetic or an epidural hematoma. Anesthesia and Analgesia 2003; 96: 1785-1788 (Pubitemid 36623142)
64. Broomhead CJ, Davies W, Higgins D. Awake fibreoptic intubation for caesarian section. International Journal of Obstetric Anaesthesia 1995; 4: 172-174